Articles tagged with Cancer Patients
The University of Texas M. D. Anderson Cancer Center is hosting its first international conference on inflammatory breast cancer to bring together clinicians and scientists to share new clinical discoveries and educational workshops. The conference aims to improve diagnosis and management of this rare but deadly disease through joint i...
Lapatinib shows improved progression-free survival for women with HER2-positive metastatic breast cancer compared to chemotherapy alone. However, high-volume laboratories misclassify some patients, preventing them from receiving optimal therapy.
Researchers found blood transfusions in hospitalized cancer patients increased venous thromboembolism (VTE) and arterial thromboembolism (ATE) rates, comparable to erythropoiesis-stimulating agents (ESAs). This study highlights the need for cautious use of transfusions and exploration of ways to reduce clot risk in cancer patients.
Head and neck cancer patients with comorbidities have a significantly higher risk of death, with some cases increasing by up to seven-fold. The study highlights the importance of considering co-existing conditions in estimating cancer survival statistics.
A study published by the American Association for Cancer Research found that cruciferous vegetables like broccoli may lower lung cancer risk in smokers. The study showed a significant protective effect, with risks ranging from 20% to 55% depending on the type and duration of smoking.
A meta-analysis published by the American Association for Cancer Research found that individuals with HIV have a higher risk of non-AIDS cancers compared to the general population. The risk is significantly higher for men than women, and incidence rates are similar between those with AIDS and without.
Researchers found that home-based diet and exercise interventions improved physical functioning in older, long-term cancer survivors. Participants in the intervention group demonstrated significant improvements in their diet and exercise behaviors, as well as measures of basic and advanced lower extremity functioning.
GUMC researchers will present several scientific findings on black women's health, including the importance of colonoscopy utilization and BRCA1/2 genetic testing. Studies reveal predictors of genetic testing among newly diagnosed breast cancer patients, highlighting the need for clinical practice to identify patients at risk.
Researchers found associations between lifestyle, behavioral, and demographic variables on cancer risk among the elderly, including moderate physical activities decreasing cancer risk. Tobacco consumption was also linked to lung cancer, while comorbidities increased breast and prostate cancer risk.
A landmark trial is underway to assess whether COLD-FX reduces infections in chronic lymphocytic leukemia patients, who are vulnerable to respiratory infections due to weakened immune systems. The study aims to evaluate the effectiveness of COLD-FX in preventing and treating viral respiratory infections.
The study found that CAPHOSOL results in a low incidence of oral mucositis, moderate to severe pain, and dysphagia. Patient satisfaction rates were high, with 79% describing themselves as satisfied or very satisfied with the treatment.
A randomized clinical trial found that breast cancer patients who participate in psychological intervention sessions experience reduced stress, improved mood, and altered health behaviors. This led to a significant decrease in cancer recurrence and death from breast cancer, as well as overall mortality.
Researchers found that DFMO treatment reduced dysplasia progression in patients with Barrett's esophagus, while also lowering putrescine levels and KLF5 expression. The study suggests a potential mechanism for the chemopreventive effects of DFMO.
A large-scale clinical trial found no significant protection against cancer from long-term vitamin E or C supplements. Researchers followed over 14,000 physicians for up to 10 years without detecting a link between these supplements and reduced cancer rates.
Researchers at Medical University of South Carolina present a new theory that may lead to effective heart failure treatments by identifying the role of matrix metalloproteinases (MMPs) in the disease. The study suggests that MMPs, similar to those found in cancerous tumors, contribute to the progression of heart failure, leading to the...
The report aims to improve cancer clinical trial participation, particularly among racial and ethnic minorities and low-income groups. It recommends integrating community representatives into the research development process and disseminating results in ways that patients can understand.
Researchers found that the use of predictive biomarkers and targeted therapies significantly delayed the need for conventional chemotherapy in patients with early-stage but high-risk chronic lymphoid leukemia (CLL). The study resulted in a four-year delay in treatment compared to two years, showing promising results for personalized care.
A study of over 200 cancer patients found that age was not a significant factor in survival rates. Instead, factors like physical quality of life and metastatic dissemination played a crucial role. The findings suggest that older patients should not be excluded from clinical trials due to their age.
Researchers at Washington University sequenced a cancer patient's genome to discover 10 unique genetic mutations relevant to her acute myelogenous leukemia. The study sets the stage for using comprehensive genome-wide approaches to diagnose and treat cancer.
Researchers at Moores UCSD Cancer Center are conducting a clinical trial of an immune-boosting vaccine, ISF35, to combat chronic lymphocytic leukemia (CLL) in high-risk patients. The therapy aims to activate the immune system and eliminate cancer cells.
A landmark UCLA study reveals that tailored treatment approaches can significantly improve kidney cancer patient survival rates, with some patients experiencing excellent outcomes of up to 97%. The study identified subsets of patients who require different levels of treatment, including surgery and targeted therapies.
Frank L. Meyskens Jr., a renowned cancer prevention researcher, has received the AACR-Prevent Cancer Foundation Award for his significant contributions to the field. His work on chemoprevention, including the development of topical all-trans-retinoic acid for cervical intraepithelial neoplasia, has moved the field forward.
Experts warn that both John McCain's and Barack Obama's healthcare plans will be significantly impacted by the $700 billion bailout. McCain's plan would cut federal insurance for the poor, while Obama's plan proposes expanded coverage with standard benefits. The bailout is expected to diminish prospects for health reform.
A new study reveals that poorer socioeconomic status increases mortality risk in non-Hodgkin lymphoma patients, while chemotherapy reduces the risk. Ethnic disparities are also observed, with African-Americans less likely to receive chemotherapy and living in poorer communities.
The VCU Massey Cancer Center will conduct two studies to examine delays and disparities in colon cancer diagnosis and physician communication patterns based on race and gender. The first study focuses on appraisal delays, while the second study uses trained actors to simulate patient interactions with primary care physicians.
Lucile L. Adams-Campbell, a renowned expert on health disparities, has been elected to the Institute of Medicine, recognized for her outstanding professional achievements and commitment to service. As a professor of oncology at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center, she will strive to enhance the n...
A landmark clinical trial is underway to test whether a low-molecule-weight heparin can prevent pulmonary embolism in patients receiving chemotherapy on an outpatient basis. The trial aims to identify high-risk cancer patients and demonstrate that blood clots can be prevented with anti-coagulant therapy.
Researchers at Dana-Farber Cancer Institute found that end-of-life discussions can lead to improved quality of life for patients and their loved ones. Patients who had these conversations were more likely to accept comfort care and received less aggressive medical treatment.
Patients who had end-of-life discussions with physicians experienced improved quality of life near death, fewer aggressive medical interventions, and better hospice enrollment. Caregivers also benefited from these conversations, with lower rates of depression and regret.
Research found that surgical tumor removal significantly elevated serum levels of TF and Tn antibodies in gastrointestinal cancer patients, particularly those with G3 tumors. The postoperative follow-up showed a correlation between the level of anti-TF IgG and lymphocyte count, as well as between anti-Tn IgG and serum CA 19-9 levels.
Researchers at The University of Texas M. D. Anderson Cancer Center have found that chemotherapy alone can be effective in treating pediatric patients with unresectable or progressive low-grade glioma, reducing the need for cranial radiation. Patients treated with thioguanine, procarbazine, lomustine and vincristine (TPCV) regimen show...
A new analysis found that African Americans and those from low-income communities have poorer survival rates for head and neck cancer, with earlier diagnosis crucial to improving outcomes. The study reveals racial disparities and socio-economic inequities in cancer treatment, highlighting the need for targeted interventions.
A study from Massachusetts General Hospital found that women with vulvar carcinoma and extra copies of the epidermal growth factor receptor (EGFR) gene are at increased risk of dying from their cancer. EGFR amplification is associated with poor survival rates, making targeted therapies a promising treatment option.
Researchers found that hepatitis B virus (HBV) exposure may increase the risk of pancreatic cancer and reactivation of HBV during chemotherapy. The study, published in the Journal of Clinical Oncology, suggests testing for HBV before administering chemotherapy to prevent liver damage.
A University of Missouri researcher has developed a new method to create cancer drugs that can be tailored to individual tumors, increasing effectiveness and reducing waste. The new method uses two-stage radioactive decay to produce nearly 100% of the intended radioactive isotope.
The study found that CAPHOSOL treatment significantly limits the occurrence and severity of oral mucositis, with high levels of medication compliance and patient/physician satisfaction reported. Compliance was very high, with nearly all patients rinsing with CAPHOSOL at least once daily.
A study using PET/CT showed an accuracy of 82.6% in detecting tumor recurrence, with clinical decisions changed for 30.4% patients. Molecular imaging technology may provide new applications for improving long-term survival in gastric cancer patients.
A team of researchers at M. D. Anderson Cancer Center has discovered a biomarker for bladder cancer using fluorescence in situ hybridization (FISH) tests on urine samples, identifying all 23 cancer cases and correctly characterizing six of seven controls as not having bladder cancer.
A meta-analysis of 22 studies found that endoscopic ultrasound (EUS) is highly accurate in staging gastric cancer, with higher sensitivity and specificity for advanced disease. EUS can help determine the most appropriate treatment approach for patients with gastric cancer, including curative or palliative therapies.
A study found that black patients undergoing screening colonoscopy have a higher prevalence of colon polyps compared to white patients. Black men and women were more likely to have large polyps, with increased odds in those over 50 years old.
Researchers found that undetectable EBV DNA levels during treatment significantly reduced cancer recurrence risk, while detectable levels increased the risk of recurrence and metastasis. The study suggests using biomarker tests before and during treatment to guide clinical therapy.
Researchers at OHSU Cancer Institute have determined that the prostate moves up and down by up to 2 millimeters during the breathing cycle, affecting radiation treatment accuracy. This new information will help doctors determine suitable margins for treatment, reducing side effects and improving patient outcomes.
A study by the University of Pittsburgh Cancer Institute found that Medicare HMO costs can be a significant barrier for cancer patients participating in clinical trials. The research suggests that the payment policy under these plans may be preventing vulnerable members of society from accessing state-of-the-art care.
Researchers at Fox Chase Cancer Center have developed a prediction tool that estimates the benefit of adding androgen deprivation therapy to radiation therapy for high-risk prostate cancer patients. The tool takes into account disease burden and individual patient characteristics, allowing for personalized treatment recommendations.
Research finds activation of Src signaling pathway contributes to treatment resistance in some patients with triple-negative breast cancer. Inhibiting this pathway holds promise as a way to overcome resistance and improve patient outcomes.
The breast cancer incidence in China is expected to increase due to lifestyle changes and adoption of Western lifestyles. Researchers predict a total of 2.5 million cases by 2012, with modifications to lifestyle and reproductive risk factors potentially preventing 270,000 cases.
Researchers at Johns Hopkins University School of Medicine developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.
A new instrument uses multispectral imaging to analyze multiple proteins in a single cancer sample, providing more information for therapy development and personalized treatment. The technology is fast, automated, and provides a quantitative read-out of protein expression levels.
A study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting found that proton therapy decreases the risk of patients developing a secondary cancer. Proton therapy is a more targeted form of external beam radiation, which delivers less radiation to bordering normal structures.
A new study from The University of Texas M. D. Anderson Cancer Center found that cancer patients who receive whole brain radiation therapy in addition to stereotactic radiosurgery have a higher risk of developing learning and memory problems. This suggests that SRS alone may be a more effective treatment option for these patients.
A short one-week course of radiation before surgery significantly reduces rectal cancer recurrence risk by 76% compared to post-operative treatment. However, this approach also causes impairment in sexual and bowel functions, affecting the quality of life for patients.
A quality assurance program improves the standard of care in cancer patients by ensuring valid and statistically significant data, enabling better treatment protocols. This program strengthens clinical trials conducted by cooperative groups and supported by the National Cancer Institute.
Researchers at Georgetown University Medical Center found that CyberKnife radiosurgery is a safe treatment option for recurrent pancreatic cancer, allowing patients to resume systemic chemotherapy quickly. The study demonstrated acceptable safety and efficacy in delivering treatment within a week's time.
Researchers found that family history, high CEA levels, cancerous perforation, tumor differentiation, and vessel cancerous emboli are significant risk factors for local recurrence. Patients with positive circumferential resection margins had a higher rate of local recurrence compared to those with negative margins.
Researchers discovered a previously unknown link between two genes associated with aging and certain types of cancer. A low-calorie diet affects the activity of these genes in worms, slowing aging progression. The study's findings have implications for understanding metabolism, longevity, and disease in humans.
Researchers found that changes in physical health status during the first year after diagnosis can predict long-term survival. Patients who died within five years exhibited no recovery in their scores, while those who survived showed improvement at the one-year mark.
A new set of tools, 'Pathways to Clinical Goals,' aims to improve the translational research process, accelerating cancer therapy approval. The six pathways address various categories, including anti-cancer agents and lifestyle alterations, to clarify and streamline the research process.
A study published in Annals of Internal Medicine found that massage therapy provided immediate benefits on pain and mood among patients with advanced cancer. The treatment improved symptoms greater than simple touch, offering a safe and effective way to provide immediate relief.
Researchers have developed new therapies targeting out-of-control growth circuits in cancer cells, leading to improved survival rates. Advances in understanding head and neck cancer have also allowed doctors to better preserve organ function and increase early detection strategies.
Penn researchers discovered that Fbx4, a naturally occurring enzyme, plays a key role in stopping the production of Cyclin D1, a protein contributing to cancer development. By understanding this mechanism, scientists can develop new therapies to reverse the process.